Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Gamida Cell -Teva Joint Venture Ltd.

Home Clinical Trial Sponsors and OrganizationsGamida Cell -Teva Joint Venture Ltd.

Gamida Cell -Teva Joint Venture Ltd.

ACTIVE

Private

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

3

2 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

1

33.3%

Trial Status Distribution

Active, not recruiting

2

66.7%

Completed

1

33.3%

Clinical Trials

Trials sponsored by this organization (3)

A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Subjects with Hematologic Malignancies following Myeloablative Therapy - ExCell

Active, not recruiting

Oct 2008100 participants

A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Subjects with Hematologic Malignancies following Myeloablative TherapyEstudio de control de cohortes histórico, internacional y multicéntrico para la evaluación de la eficacia y seguridad del transplante de StemEx®, hemocitoblastos de cordón umbilical y células progenitoras expandidas ex vivo, en pacientes que padecen neoplasias hematológicas, a continuación del tratamiento mielosupresor - ExCell

Active, not recruiting

Dec 2007100 participants

Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy

Oct 2007101 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials3
Approvals
News

Back to Organizations